Metoprolol Succinate Tablet, Extended Release shortage
To Be Discontinued 7 presentations · 1 manufacturers · first FDA posting 2026-08-31 · last update 2026-08-31
Manufacturers: Teva Pharmaceuticals USA, Inc.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Metoprolol Succinate, Tablet, Extended Release, 50 mg (NDC 45963-676-11) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 08/31/2026 Updated 08/31/2026 Discontinued 08/31/2026 |
| Metoprolol Succinate, Tablet, Extended Release, 50 mg (NDC 45963-676-96) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 08/31/2026 Updated 08/31/2026 Discontinued 08/31/2026 |
| Metoprolol Succinate, Tablet, Extended Release, 100 mg (NDC 45963-677-11) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 08/31/2026 Updated 08/31/2026 Discontinued 08/31/2026 |
| Metoprolol Succinate, Tablet, Extended Release, 100 mg (NDC 45963-677-96) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 08/31/2026 Updated 08/31/2026 Discontinued 08/31/2026 |
| Metoprolol Succinate, Tablet, Extended Release, 200 mg (NDC 45963-678-11) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 08/31/2026 Updated 08/31/2026 Discontinued 08/31/2026 |
| Metoprolol Succinate, Tablet, Extended Release, 25 mg (NDC 45963-709-11) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 08/31/2026 Updated 08/31/2026 Discontinued 08/31/2026 |
| Metoprolol Succinate, Tablet, Extended Release, 25 mg (NDC 45963-709-96) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 08/31/2026 Updated 08/31/2026 Discontinued 08/31/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)